Soluble HIV-1 envelope glycoprotein trimers
US10058604B2 · kind B2 · utility
3Cited by
1References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 7, 2014 |
| Grant date | Aug 28, 2018 |
| Priority date | — |
| Expiry date | Oct 7, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to novel HIV-1 envelope glycoproteins which may be utilized as an HIV-1 vaccine immunogens, antigens for crystallization and for the identification of broad neutralizing antibodies. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.